Table 2 Patient characteristics.
From: Image guided dose escalated prostate radiotherapy: still room to improve
Age | Â |
Median (range) | 71 Years (45 - 84) |
Clinical T-category | Â |
   T1b | 1 |
   T1c | 83 (T1 32%) |
   T2a | 125 |
   T2b | 15 (T2 65%) |
   T2c | 28 |
   T3a | 2 |
   T3b | 2 (T3 2%) |
   TX | 3 |
Gleason score | Â |
   5-6 | 96 (37%) |
   7 | 141 (55%) |
   8-10 | 21 (8%) |
Initial PSA (ng/mL) | Â |
Median (range) | 7.6 (0.26-51.4) |
Risk stratification | Â |
   Low | 59 (22%) |
   Intermediate | 163 (63%) |
   High | 37 (14%) |
Radiotherapy Treatment | Â |
   3-Dimensional Conformal | 226 (87%)33 |
   IMRT | (13%) |